Fairfax Financial avatar

Shareholder letter / fund letter · 2024-03-08

Fairfax Financial 2023 Annual Report / Prem Watsa Letter

Fairfax Financial · Prem Watsa

Atlas Related party transactions Insurance profits Governance FRFHF FFH.TO

AI summary and analysis

Fairfax's 2023 annual report covering Atlas/Poseidon, insurance profits, investment portfolio and corporate governance is an important source for observing Watsa's capital allocation and related party transaction disclosures.

Key points

  • The 2023 annual report contains background on transactions such as Atlas/Poseidon, which will help investors understand Fairfax's treatment of non-insurance assets and associates.
  • Watsa continues to explain book value, insurance float, and portfolio returns in a long-term shareholder letter vein.
  • The disclosure of related party transactions in the annual report is important to Fairfax because Watsa's personal control is closely related to the company's capital allocation.
  • Insurance underwriting performance and investment income jointly determine Fairfax's long-term compounding, and one should not look solely at public equity positions.
  • This information adds context to capital allocation beyond 13F.

Other viewpoints from the same firm

Fairfax Financial 2024 Annual Report / Prem Watsa Letter

Fairfax 2024 annual report and Watsa shareholder letter review insurance growth, investment returns, buybacks, holding company financial strength and long-term book value compounding.

Shareholder letter / fund letter

Fairfax Financial 2022 Annual Report / Prem Watsa Letter

Fairfax's 2022 annual report discusses insurance pricing, fixed income reinvestment, investment gains and losses and holding company defensiveness amid rising interest rates and market volatility.

Shareholder letter / fund letter

Fairfax Financial 2021 Annual Report / Prem Watsa Letter

Fairfax's 2021 annual report shows the company's record net profit and book value growth, Watsa discusses insurance business recovery, investment income and post-pandemic capital allocation.

Shareholder letter / fund letter